Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengjun Liao

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccines|July 27, 2024
Progress and Challenges to Hepatitis E Vaccine Development and DeploymentXingcheng Huang, Jiaoxi Lu, Mengjun Liao, et al.
NPJ Vaccines|December 20, 2024
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatusKongxin Zhu, Mengjun Liao, Lu Chen, et al.
Nature Communications|February 17, 2025
Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design studyChunlan Zhuang, Xiaohui Liu, Xingcheng Huang, et al.
NPJ Vaccines|December 17, 2025
Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccineMengjun Liao, Jiali Quan, Kongxin Zhu, et al.
International Journal of Cancer|December 13, 2024
The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort studyQi Chen, Xingmei Yao, Jiali Quan, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccines|July 27, 2024
Progress and Challenges to Hepatitis E Vaccine Development and DeploymentXingcheng Huang, Jiaoxi Lu, Mengjun Liao, et al.
NPJ Vaccines|December 20, 2024
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatusKongxin Zhu, Mengjun Liao, Lu Chen, et al.
Nature Communications|February 17, 2025
Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design studyChunlan Zhuang, Xiaohui Liu, Xingcheng Huang, et al.
NPJ Vaccines|December 17, 2025
Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccineMengjun Liao, Jiali Quan, Kongxin Zhu, et al.
International Journal of Cancer|December 13, 2024
The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort studyQi Chen, Xingmei Yao, Jiali Quan, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
Pageof 1